Cargando…
Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels
INTRODUCTION: Management of phenylketonuria (PKU) is achieved through low-phenylalanine (Phe) diet, supplemented with low-protein food and mixture of free-synthetic (FS) amino acid (AA). Casein glycomacropeptide (CGMP) is a natural peptide released in whey during cheese-making and does not contain P...
Autores principales: | Ahring, Kirsten K., Lund, Allan M., Jensen, Erik, Jensen, Thomas G., Brøndum-Nielsen, Karen, Pedersen, Michael, Bardow, Allan, Holst, Jens Juul, Rehfeld, Jens F., Møller, Lisbeth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817308/ https://www.ncbi.nlm.nih.gov/pubmed/29511574 http://dx.doi.org/10.1155/2018/6352919 |
Ejemplares similares
-
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
por: Daly, A., et al.
Publicado: (2019) -
The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model
por: Ahring, Kirsten K., et al.
Publicado: (2022) -
Glycomacropeptide in PKU—Does It Live Up to Its Potential?
por: Daly, Anne, et al.
Publicado: (2022) -
The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial
por: Daly, Anne, et al.
Publicado: (2019) -
Adaptation and Validation of a Questionnaire to Evaluate Knowledge of the Low Phe Diet in PKU
por: Ramos-Álvarez, Rodolfo, et al.
Publicado: (2021)